Latest updates for Semaglutide

Fresh curated links around Semaglutide are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • OneSource Q1FY27 slides: semaglutide drives 37% revenue growth
  • Semaglutide Linked To 40% Fewer Asthma Attacks
  • Ozempic and Wegovy may have an unexpected mental health benefit

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

investing.com /1 month ago

OneSource Q1FY27 slides: semaglutide drives 37% revenue growth

Read source
drugs.com /5 hours ago

Semaglutide Linked To 40% Fewer Asthma Attacks

WEDNESDAY, Sept. 9, 2026 — A widely used weight-loss and diabetes drug may offer a surprising bonus: healthier lungs."GLP-1 receptor agonists are widely used to treat type 2 diabe...

Read source
sciencedaily.com /1 day ago

Ozempic and Wegovy may have an unexpected mental health benefit

Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar d...

Read source
newswire.com /1 month ago

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated

As more consumers seek structured, provider-guided weight management support in 2026, this VivioMD GLP-1 review explores the platform's advertised care experience, treatment-access...

Read source
kevinmd.com /1 month ago

Semaglutide and cravings: what the 2026 trial changed

Patients start glucagon-like peptide-1 (GLP-1) drugs expecting to think less about food. They did not expect to think less about alcohol. The nightly drink became easier to skip. C...

Read source
healio.com /3 weeks ago

GLP-1 reduces rates of post-bariatric hypoglycemia

A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...

Read source
drugs.com /1 month ago

Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds

FRIDAY, July 24, 2026 — Worried that your Ozempic is becoming less effective over time?Don’t worry — you’re still eating less, even if you are feeling a bit hungrier, a new study...

Read source
readunwritten.com /1 month ago

How Long Does It Take To See Results From Semaglutide?

When I first started semaglutide, I had a mix of hope and nervousness. I found myself wondering how long it would take before I noticed real results. I was adjusting how I ate, pla...

Read source
scitechdaily.com /3 weeks ago

New Research May Change How We Think About Weight Loss Drugs Like Ozempic

Why do drugs like Ozempic produce far greater and more lasting weight loss than older appetite suppressants? Scientists are beginning to uncover an unexpected answer in the brain....

Read source
neurosciencenews.com /1 month ago

Oral Ozempic Cuts Heavy Drinking and Cravings

Oral semaglutide reduces heavy drinking days, daily cravings, and alcohol-related problems in adults with Alcohol Use Disorder.

Read source
newswire.com /17 hours ago

MEDGm GLP-1 Review 2026: Is the $169 Starting Price the Telehealth Weight-Management Deal It First Appears to Be? Costs...

As GLP-1 telehealth demand remains high in 2026, this MEDGm review takes a closer look at the brand-stated $169 starting price, compounded semaglutide and tirzepatide options, bran...

Read source
fodmapeveryday.com /1 day ago

Scientists found another surprising effect of semaglutide, and it may have nothing to do with weight loss

Semaglutide has become famous for what it does to the waistline. But researchers are increasingly interested in what GLP-1 drugs might be doing elsewhere in the body. Now a large n...

Read source
qchron.com /2 weeks ago

CoreAge Rx Expands Weight & Metabolic Health Offerings with Affordable, Doctor-Guided Semaglutide and Tirzepatide Pr...

Read source
scitechdaily.com /1 week ago

The Rare Vision Side Effect of Ozempic and Wegovy You Should Know About

Rutgers researchers say the risk is low, but patients should still be aware of the possible association. GLP-1 medications have become widely used for Type 2 diabetes and obesity,...

Read source
nytimes.com /1 week ago

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

Read source
thehindubusinessline.com /1 month ago

RPGLS growth plans includes semaglutide launch and plant acquisition

Outlining plans for growth, Nair said, they are scouting for a manufacturing facility in India, and were willing to spend between Rs ₹700 to Rs ₹1,000 crore

Read source
scitechdaily.com /3 weeks ago

Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs

New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of medications. Millions of people are now using GLP-1 receptor agonis...

Read source
newswire.com /3 weeks ago

BetterMe Rx GLP-1 Review 2026: Is This the GLP-1 Weight-Management Option You’ve Been Looking For? See How the Online Pr...

As interest in online GLP-1 weight-management care continues in 2026, this BetterMe Rx review examines the telehealth evaluation process, compounded semaglutide and tirzepatide opt...

Read source
pharmexec.com /1 month ago

<![CDATA[Eli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs]]>

Read source
hospitalnews.com /1 week ago

Generic semaglutide could reshape diabetes drug coverage in Canada

The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up to 2.1 million Canadians living with T...

Read source
newswire.com /1 month ago

Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals?

As more adults compare convenient and potentially more affordable GLP-1 care in 2026, this Zevay review explores advertised semaglutide and tirzepatide pricing, online provider eva...

Read source
newswire.com /1 month ago

Lttl GLP-1 Review 2026: Could “Same Price at Every Dose” Be the Telehealth Pricing Shift Buyers Have Been Waiting For?

As cash-pay consumers compare GLP-1 telehealth programs in 2026, this Lttl review examines the brand-stated "same price at every dose" model, compounded semaglutide and tirzepatide...

Read source
bioengineer.org /1 month ago

Oral Semaglutide Trial Suggests Fewer Heavy Drinking Days in Alcohol Use

A new clinical trial led by researchers at the University of Colorado Anschutz suggests that oral semaglutide—a medication best known for treating type 2 diabetes and for weight ma...

Read source
medicalxpress.com /1 week ago

Fighting childhood obesity: Researchers study semaglutide with adolescents

Kentucky has one of the highest childhood obesity rates in the country, and the health consequences carry forward throughout life. That's one of the reasons researchers at the Univ...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Semaglutide

feeds.feedburner.com

Recent coverage from public sources
Public source

readunwritten.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

hospitalnews.com

Recent coverage from public sources
Public source

medicalxpress.com

Recent coverage from public sources
Public source